Recent Posts
- AsclepiX Therapeutics, Inc. Appoints Robert J. Dempsey as Chief Executive Officer and President
- AsclepiX Therapeutics partners with Notal Vision on Home OCT remote monitoring in DME and AMD clinical trials
- Barer & Son Capital and Hibiscus Capital Management Announce Successful Initial Public Offering of Portfolio Company NexImmune
- NexImmune Announces Pricing of Upsized Initial Public Offering
- Immunotherapy Veteran Robert Knight, MD, Joins NexImmune as Chief Medical Office
